Home | Welcome to Contract Pharma   
Last Updated Thursday, October 30 2014
Print

Quintiles Named BMS Preferred Provider



By Gil Roth



Published April 11, 2013
Quintiles has been chosen as a preferred provider by Bristol-Myers Squibb Company (BMY) to provide global support for Bristol-Myers Squibb’s central lab work, biomarker testing and assay development for the next five years.

“This agreement deepens the commitment our companies share to providing patients access to effective, safe and affordable treatments,” said Thomas Wollman, senior vice president of Quintiles Global Laboratories. “We look forward to working with Bristol-Myers Squibb to bring personalized medicine into mainstream drug development.”


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On